United States securities and exchange commission logo December 14, 2020 Harry Simeonidis Chief Executive Officer and President GBS Inc. 708 Third Avenue, 6th Floor New York, New York 10017 Re: GBS Inc. Amendment No. 10 to Registration Statement on Form S-1 Filed December 8, 2020 File No. 333-232557 Dear Mr. Simeonidis: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our November 24, 2020 letter. Amendment No. 10 to Registration Statement of Form S-1 filed December 8, 2020 General 1. Exhibit 4.6 stipulates that an investor must submit to the exclusive jurisdiction of state and federal courts located in the City of New York for all legal proceedings arising out of or relating to the common stock warrant. Revise the disclosure in the section captioned "Risk Factors" and in the prospectus to make clear whether this provision applies to actions arising under the Securities Act or the Exchange Act. We note that Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or its rules and regulations and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or its rules and Harry Simeonidis GBS Inc. December 14, 2020 Page 2 regulations. If this provision applies to Securities Act claims, revise the disclosure in the prospectus to state that there is uncertainty on whether a court would enforce the provision and that investors cannot waive compliance with the federal securities laws and their rules and regulations. If this provision does not apply to actions arising under the Securities Act or the Exchange Act, ensure that the provision and the disclosure in the prospectus both state this clearly. You may contact Michael Fay at (202) 551-3812 or Brian Cascio at (202) 551-3676 if you have questions regarding comments on the financial statements and related matters. Please contact Tim Buchmiller at (202) 551-3635 or Geoff Kruczek at (202) 551-3641 with any other questions. Sincerely, FirstName LastNameHarry Simeonidis Division of Corporation Finance Comapany NameGBS Inc. Office of Manufacturing December 14, 2020 Page 2 cc: Ralph V. De Martino, Esq. FirstName LastName